SFCC provides outsourced drug development research services Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SFCC provides outsourced drug development research services

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Skywatcher who wrote (7)	11/4/2001 2:53:18 PM
From: Skywatcher	Read Replies (1) of 29

SFBC International, Inc. to Buy Back Up to 500,000 Shares MIAMI--(BUSINESS WIRE)--Sept. 19, 2001--SFBC International, Inc. (Nasdaq:SFCC - news) a leading provider of specialized, outsourced drug development research services to the pharmaceutical and biotechnology industries, today announced that it approved the repurchase of up to 500,000 shares of its common stock. SFBC International said it plans to repurchase shares in the open market at times and prices that it considers appropriate based upon market conditions. Dr. Lisa Krinsky, chairman of the board, stated ``We believe nothing has changed the fundamental strength and prospects of our business. We will continue to execute our long-term corporate strategy of seeking to increase stockholder value.'' Only problem is that they should have done this when the stock was in the LOW TEENS....not now....and it would have helped to reduce the huge increase in outstanding shares which whacked us a LOT in two days following outstanding earnings and revenues. CC

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next